Terumo Cardiovascular Logo
  

Terumo Announces Change of Executive Officers

TOKYO, JAPAN — February 6, 2020 — Terumo Corporation (TSE: 4543) hereby announces that it has resolved a change of its Executive Officers as follows.

1. Change of Executive Officers (As of April 1, 2020)

Name New Title Current Title

Hikaru Samejima

Managing Executive Officer
President, General Hospital Company
Division President, Hospital
Systems Division, General Hospital Company

Managing Executive Officer
President, Cardiac and Vascular Company
Division President, Interventional
Systems Division, Cardiac and Vascular Company

Toshihiko Osada

Managing Executive Officer
President, Cardiac and Vascular Company
Division President, Interventional Systems Division,
Cardiac and Vascular Company

Senior Executive Officer
General Manager, Strategic Planning Dept.

Itaru Sakaguchi

Senior Executive Officer
Chief Operations Officer (COO),
Interventional Systems Division,
Cardiac and Vascular Company

Executive Officer
Chief Operations Officer (COO),
Interventional Systems Division,
Cardiac and Vascular Company

Hiroshi Nagumo

Executive Officer
President and CEO,
Terumo Americas Holding, Inc.
Regional Representative, Latin America

Executive Officer
Senior Vice President, Blood
Center Solutions, Terumo BCT Holding Corp.
President and Representative
Director, Terumo BCT Japan, Inc.
Production Dept. (Terumo BCT)

Fumihisa Hirose

Executive Officer
General Manager,
Strategic Planning Dept.

Executive Officer
Senior Vice President,
Cardiac and Vascular Company
Senior Vice President, ME R&D,
Cardiac and Vascular Company

Kenichi Ikeda

Executive Officer
General Manager, Sales Promotion (Japan),
Hospital Systems Division,
General Hospital Company

Branch Manager, Osaka Branch,
General Hospital Company

Kazunobu Handa

Executive Officer
General Manager,
Corporate Affairs Dept.

General Manager,
Corporate Affairs Dept.

Toshio Nakashima

Executive Officer
Chief Quality Officer (CQO)
General Manager, Quality Assurance Dept.
Post-Market Surveillance and Vigilance Dept.

General Manager,
Quality Assurance Dept.

Takeshi Kuroo

Executive Officer
Senior Vice President, Surgical Business,
Cardiac and Vascular Company
General Manager, HeartSheet Business Dept.,
Cardiac and Vascular Company

Factory Manager, Ashitaka Factory,
Cardiac and Vascular Company

Robert DeRyke

Executive Officer
Division President, Cardiovascular Division,
Cardiac and Vascular Company
President and CEO,
Terumo Cardiovascular Systems Corp.

Division President, Cardiovascular Division,
Cardiac and Vascular Company
President and CEO,
Terumo Cardiovascular Systems Corp.

About Terumo

Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for nearly 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide, to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been bolstering healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. Terumo will further strive to be of value to patients, medical professionals, and society at large.